SLRN Shares Outstanding History



Below is a table of the SLRN shares outstanding history going back to 6/13/2023:

Date SLRN Shares Outstanding
6/13/202397.20M
8/10/202397.24M
11/6/202397.34M

Also see: SLRN Market Cap History
SLRN YTD Return
SLRN Historical Shares Outstanding:
+0.36% CAGR
SLRN Historical Shares Outstanding: +0.36% CAGR

Mouse over chart for data details
6/13/2023 ...11/6/2023
ACELYRIN is engaged in the identification, acquisition, development and commercialization of medicines for autoimmune and inflammatory diseases. Co.'s clinical and preclinical stage product candidates consisting of: izokibep, which is a small protein therapeutic designed to inhibit anti-interleukin-17A; lonigutamab, which is a humanized immunoglobulin G1 (IgG1) monoclonal antibody against insulin-like growth factor 1 receptor for the treatment of chronic urticaria; and SLRN-517, which is a fully human IgG1 monoclonal antibody targeting c-KIT for the treatment of chronic urticaria. We show 3 historical shares outstanding datapoints in our coverage of SLRN's shares outstanding history.

Understanding the changing numbers of SLRN shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like SLRN versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching SLRN by allowing them to research SLRN shares outstanding history as well as any other stock in our coverage universe.
Quotes delayed 20 minutes

Email EnvelopeFree SLRN Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: Shares Outstanding Importance


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
ACELYRIN (SLRN) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:

SLRX Shares Outstanding History
SLS Shares Outstanding History
SMLR Shares Outstanding History
SMMT Shares Outstanding History
SMTI Shares Outstanding History
SNBP Shares Outstanding History
SNCA Shares Outstanding History
SNDA Shares Outstanding History
SNDX Shares Outstanding History
SNGX Shares Outstanding History
More Healthcare companies »

 

SLRN Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2024, All Rights Reserved

Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.